Clinically, SIAH1 was found to be downregulated in liver cancer samples (Fig. 7J, K), and there was a directly negative correlation between SIAH1 and ADRM1 protein levels in normal and liver cancer specimens (Fig. 7L). Here, SIAH1 is linked to liver cancer.